Epidemiology, Diagnosis, and Outcomes of Pediatric Burkitt Lymphoma Patients Treated at Bugando Medical Centre in Mwanza, Tanzania. (Record no. 27941)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 03904nam a22002897a 4500 |
001 - CONTROL NUMBER | |
control field | 20240606173035.0 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | 20240606173035.0 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20240606173602.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 240606b |||||||| |||| 00| 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | Online ISSN 1538-7755 |
International Standard Serial Number | Print ISSN 1055-9965 |
040 ## - CATALOGING SOURCE | |
Transcribing agency | ddc |
041 ## - LANGUAGE CODE | |
Language code of text/sound track or separate title | English |
100 ## - MAIN ENTRY--PERSONAL NAME | |
Fuller form of name | Hutton Chapman |
245 ## - TITLE STATEMENT | |
Title | Epidemiology, Diagnosis, and Outcomes of Pediatric Burkitt Lymphoma Patients Treated at Bugando Medical Centre in Mwanza, Tanzania. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Place of publication, distribution, etc. | Mwanza, Tanzania : |
Name of publisher, distributor, etc. | Catholic University of Health and Allied Sciences [CUHAS – Bugando] : |
Date of publication, distribution, etc. | 2023 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | Includes References |
490 ## - SERIES STATEMENT | |
Series statement | Cancer Epidemiol Biomarkers Prev (2023) 32 (6_Supplement): 33. |
520 ## - SUMMARY, ETC. | |
Summary, etc. | Abstract :<br/><br/>Purpose: Despite the significant improvement in outcomes over the last few decades for the treatment of pediatric Burkitt lymphoma, outcomes in sub-Saharan Africa remain poor, with an approximately 50% survival rate. This disparity is likely multifactorial and significant work remains to improve these outcomes in low resource settings. As a first step in attempting to improve these disparate outcomes at our hospital, Bugando Medical Centre (BMC), in Mwanza, Tanzania, we aim to improve the understanding of the presentation, diagnosis, and outcomes with the current standard of care therapy at our site. We propose that a better understanding of the current nature of care for these patients at our site will allow for more informed future interventions aimed at improving outcomes.<br/><br/>Methods: Historical patient data were abstracted for pediatric patients with a diagnosis of Burkitt lymphoma treated at BMC from 2016-2022. Patients’ initial presentations (e.g. site of disease), means of diagnosis, treatment completion rate, and outcomes (if available) were analyzed.<br/><br/>Results: Data were available on 109 patients with a diagnosis of Burkitt lymphoma between 2016-2022. Patients were on average 7.7 years old at presentation. We observed a 2:1 male to female ratio. We observed a significant proportion of abdominal disease with 58.7% presenting with abdominal disease (either alone or in combination) at initial diagnosis. There were 91% of patients who were deemed INCTR ‘high risk’ at diagnosis. There was a notable improvement in the percent of patients diagnosed with a biopsy with 46% in 2016 and 100% in 2022. Outcomes were poor but were difficult to assess with clarity due to a high rate of abandonment. Within those limitations, we observed a 1-year overall survival, of patients through 2021 with known outcomes, of 50.2% and a 1-year event free survival of 34.1% (including abandoment as an event).<br/><br/>Conclusion: Overall, in our patients we note epidemiology consistent with known data for endemic Burkitt lymphoma. Our patient population includes a significant proportion of abdominal and/or high-risk disease. We demonstrate overall poor outcomes with a high degree of treatment abandonment. These data suggest that improvement in treatment efficacy and treatment adherence may improve outcomes.<br/><br/>Citation Format: Hutton Chapman, Paul S. Ntemi, Jacqueline Kamanga, Judith Paschal, Heronima J. Kashaigili, Kristin Schroeder. Epidemiology, Diagnosis, and Outcomes of Pediatric Burkitt Lymphoma Patients Treated at Bugando Medical Centre in Mwanza, Tanzania [abstract]. In: Proceedings of the 11th Annual Symposium on Global Cancer Research; Closing the Research-to-Implementation Gap; 2023 Apr 4-6. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2023;32(6_Suppl):Abstract nr 33. |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Fuller form of name | Kristin Schroeder |
Fuller form of name | Heronima J. Kashaigili |
Fuller form of name | Judith Paschal |
Fuller form of name | Jacqueline Kamanga |
Fuller form of name | Paul S. Ntemi |
856 ## - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href=" https://doi.org/10.1158/1538-7755.ASGCR23-Abstract-33"> https://doi.org/10.1158/1538-7755.ASGCR23-Abstract-33</a> |
Link text | https://doi.org/10.1158/1538-7755.ASGCR23-Abstract-33 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Source of classification or shelving scheme | ddc |
Koha item type | RESEARCH ARTICLES |
Suppress in OPAC |
Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Total checkouts | Barcode | Date last seen | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|
MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 06/06/2024 | 20240606173035.0 | 06/06/2024 | 06/06/2024 | RESEARCH ARTICLES |